From: "Anita Person" <colonist57634@aol.com>
To: <vasvir@iit.demokritos.gr>,
	<nvas@iit.demokritos.gr>,
	<paliourg@iit.demokritos.gr>
Subject:  OTC FIRST ALERT - PDPR's Pediatric Fittings Funded by Panhandle Lions Club of Texas and Medicaid
Date: Tue, 27 Jan 2004 07:32:26 +0300
MIME-Version: 1.0
Content-Type: text/html;
	charset="iso-8859-7"
Content-Transfer-Encoding: quoted-printable
X-Priority: 3
X-MSMail-Priority: Normal
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.2527

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<META HTTP-EQUIV=3D"Content-Type" CONTENT=3D"text/html; =
charset=3Diso-8859-7">
<META NAME=3D"Generator" CONTENT=3D"MS Exchange Server version =
6.5.7036.0">
<TITLE> OTC FIRST ALERT - PDPR's Pediatric Fittings Funded by =
Panhandle Lions Club of Texas and Medicaid</TITLE>
</HEAD>
<BODY>
<!-- Converted from text/plain format -->

<P><FONT SIZE=3D2>Symbol: PDPR<BR>
Market: PK<BR>
Sector: $100 million Infant-Pediatric Prosthetics Market<BR>
<BR>
<BR>
BREAKING NEWS:&nbsp; HOUSTON, Jan 26, 2004 (BUSINESS WIRE) PDPR =
announces that<BR>
The Panhandle Lions Clubs of Texas has funded two arms for a beautiful =
young<BR>
girl in their community. She had no hands, but now she has two hands to =
aid<BR>
her in living a more independent life.<BR>
<BR>
&gt;&gt; Medicaid and other insurance companies will be funding more =
than 70<BR>
&gt;&gt; infant prosthetic fittings this year, which will create =
annual<BR>
&gt;&gt; positive revenue for PDPR of nearly $1.5 million<BR>
<BR>
&gt;&gt; The Panhandle Lions Clubs of Texas has teamed up with PDPR to =
fund Texas<BR>
children in need of a infant prosthetic fittings and are =
uninsured.&nbsp;<BR>
<BR>
<BR>
BREAKING NEWS:&nbsp; LAKE HARMONY, PA, Jan. 23, 2004 (MARKET WIRE via =
COMTEX) --<BR>
IOCircuit.com reiterates a Buy rating and announces the completing =
of<BR>
build-out of the pediatric lab/clinic at 12926 Willowchase, Houston. =
Feb. 1,<BR>
2004 is the planned grand opening<BR>
<BR>
<BR>
<BR>
The national prosthetics market is estimated at nearly $2 billion =
annually<BR>
and is extremely fragmented.&nbsp;&nbsp; PDPR's infant prosthetic =
segment of this<BR>
market is estimated at $100 million<BR>
&nbsp;&nbsp;&nbsp;<BR>
&gt;&gt; Jim Furey of Lehman Brothers says, &quot;You want to own small =
stocks versus<BR>
large stocks when economic growth is accelerating, which is exactly =
the<BR>
period we're in now.&quot;<BR>
&nbsp;&nbsp;<BR>
PDPR's a NEW Public company that's primed to dominate this $100 =
million<BR>
Infant-Pediatric Prosthetics segment.&nbsp;<BR>
&nbsp;&nbsp;<BR>
In its segment, PDPR's hope is to repeat the success Hanger, Inc.&nbsp; =
Hanger,<BR>
Inc. currently trades on the (NYSE &quot;HGR&quot;), and has a market =
cap of approx.<BR>
$366 million<BR>
<BR>
&gt;&gt; Currently PDPR is the only company focusing on the unique needs =
of<BR>
&gt;&gt; the infant-pediatric prosthetics segment<BR>
<BR>
<BR>
<BR>
PEDIATRIC PROSTHETICS MARKET<BR>
<BR>
Children ages 0 to 14 comprise $100 million of the total $2 billion =
national<BR>
prosthetic market.&nbsp; The vast majority of this pediatric prosthetic =
market<BR>
derives from infants born with a limb loss.<BR>
<BR>
This infant prosthetic segment allows PDPR to generate a consistent =
revenue<BR>
stream from childhood to adulthood.&nbsp; Revenue from infancy to =
adulthood is<BR>
anticipated to be over $200,000, with adults spend an additional =
$200,000.&nbsp;<BR>
<BR>
<BR>
Medicaid and other insurance companies will be funding more than 70 =
infant<BR>
prosthetic fittings this year, which will create annual positive revenue =
for<BR>
PDPR of nearly $1.5 million<BR>
<BR>
1. Of these 70 infant fittings, each year each child will need a =
re-socket<BR>
re-build generating $630,000 annually.&nbsp;<BR>
<BR>
2. Every third year these same 70 fittings will need a completely =
new<BR>
prosthetic limb again generating $1.5 million for PDPR.<BR>
<BR>
3. The total revenue generated from these initial 70 fittings, from =
infancy<BR>
to adulthood, is approximately $14 million!<BR>
<BR>
This &quot;annuity effect&quot; will compound earnings each year and =
enable PDPR to<BR>
enjoy stable growth and profitability over the short and long term.<BR>
<BR>
<BR>
<BR>
PDPR MANAGEMENT TEAM<BR>
<BR>
The management team of PDPR is nationally recognized as the leading<BR>
prosthetists in the infant-pediatric prosthetics field.&nbsp; PDRP's =
management's<BR>
been featured in, &quot;Orthotics &amp; Prosthetics Business News&quot;, =
written up in<BR>
&quot;Life Magazine&quot;, and some of the fitted children have appeared =
on national<BR>
TV shows, including&nbsp; &quot;Good Morning America&quot;, &quot;Maury =
Povich&quot;, &quot;Phil Donahue&quot;,<BR>
and &quot;20-20&quot;.<BR>
<BR>
<BR>
<BR>
FINAL CONSIDERATIONS<BR>
<BR>
PDPR developed a strong niche in the nearly $100 million =
infant-pediatric<BR>
need.&nbsp;<BR>
<BR>
&gt;&gt; PDPR is the only company specializing in the national needs of =
the<BR>
Infant-Pediatric Prosthetics segment.<BR>
<BR>
&gt;&gt; Focusing on its segment will allow PDPR to generate a =
consistent revenue<BR>
stream from childhood to adulthood.&nbsp; The &quot;annuity effect&quot; =
will compound<BR>
earnings each year and enable PDPR to enjoy stable growth and =
profitability<BR>
over the short and long term.<BR>
<BR>
<BR>
<BR>
<BR>
Receive First Notice on Companies like PDPR =
(first_alert@otcfirstalert.com)<BR>
<BR>
<BR>
<BR>
<BR>
<BR>
<BR>
The information herein is for information purposes only and should not =
be<BR>
construed as an offer or solicitation of an offer to buy or to sell<BR>
securities. This assembled information is based on information supplied =
by<BR>
the company, press releases, SEC filings, or from other sources believed =
to<BR>
be reliable, but no representation, expressed or implied, is made as to =
its<BR>
accuracy, completeness or correctness. The data contained herein is =
subject<BR>
to change without notice. Small-cap companies, micro-cap companies, =
penny<BR>
stocks and/or thinly traded securities are inherently risky and =
volatile;<BR>
therefore the risk of losing some or all should be calculated. Please =
always<BR>
do your own due diligence and consult a financial advisor. =
OTCFirstAlert<BR>
accepts no liability for any losses arising from an investor's reliance =
on<BR>
or use of this report. Affiliates of OTCFirstAlert have been hired by =
a<BR>
third party and are to one million trading shares for the construction =
and<BR>
dissemination of this information. OTCFirstAlert and its affiliates,<BR>
officers, directors, members and employees may hold, buy or sell =
common<BR>
shares of profiled companies in the open market without notice. On =
technical<BR>
analysis may from time to time cause the target price to fluctuate =
without<BR>
notice. Certain information included herein is forward-looking within =
the<BR>
meaning of the Private Securities Litigation Reform Act of 1995, =
including,<BR>
but not limited to, statements concerning manufacturing, marketing, =
growth,<BR>
and expansion. Such forward-looking information involves important risks =
and<BR>
uncertainties that could affect actual results and cause them to =
differ<BR>
materially from expectations expressed herein.<BR>
<BR>
6 Eftute Ave<BR>
Kingston 10<BR>
Jamaca WI<BR>
<BR>
</FONT>
</P>

</BODY>
</HTML>
